|
MORF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.65740000000114E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.550300E-04 |
| Normal-vs-Stage2 |
5.777800E-04 |
| Normal-vs-Stage3 |
2.49849999999219E-05 |
| Normal-vs-Stage4 |
7.622700E-03 |
| Stage1-vs-Stage2 |
3.026200E-01 |
| Stage1-vs-Stage3 |
5.359900E-02 |
| Stage1-vs-Stage4 |
4.180200E-01 |
| Stage2-vs-Stage3 |
9.390400E-01 |
| Stage2-vs-Stage4 |
9.513800E-01 |
| Stage3-vs-Stage4 |
9.883200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.92240000000044E-05 |
| Normal-vs-AfricanAmerican |
4.758300E-03 |
| Normal-vs-Asian |
1.285740E-02 |
| Caucasian-vs-AfricanAmerican |
2.532800E-01 |
| Caucasian-vs-Asian |
3.501600E-01 |
| AfricanAmerican-vs-Asian |
1.874640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.08030000009774E-07 |
| Normal-vs-Female |
4.792300E-02 |
| Male-vs-Female |
3.698300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.397600E-03 |
| Normal-vs-Extreme_Weight |
1.71031999999238E-05 |
| Normal-vs-Obese |
4.997700E-03 |
| Normal-vs-Extreme_Obese |
1.250240E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.911400E-01 |
| Normal_Weight-vs-Obese |
7.764400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.837600E-01 |
| Extreme_Weight-vs-Obese |
1.368820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.812400E-01 |
| Obese-vs-Extreme_Obese |
8.093000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.159500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.812000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.31200000003307E-06 |
| Normal-vs-Age(81-100Yrs) |
3.185600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.869800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.266800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.746400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.355800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.739000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.536800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.42449999999983E-05 |
| Normal-VS-Type2 PRCC |
1.183450E-03 |
| Normal-VS-KIRP CIMP |
8.201800E-02 |
| Normal-VS-Unclassified PRCC |
2.965100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.805800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.454400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.026000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.373000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.588800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.753600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.14290000000372E-05 |
| Normal-vs-N1 |
3.684100E-03 |
| Normal-vs-N2 |
1.771560E-01 |
| N0-vs-N1 |
4.033200E-01 |
| N0-vs-N2 |
6.013400E-01 |
| N1-vs-N2 |
9.305400E-01 |
|
|
